Pharma IQ: In predictive toxicology what difference does the small molecule versus
large molecule make?
Stephen Kirk: The biggest difference is with regards to the small molecule there’s more of a structured process for predictive pre-clinical toxicological studies and you’re looking more for kind of off target toxicity, whereas with a larger molecule it’s very specific, so you’re looking more for an exaggerated pharmacology type response and looking for
specific t...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More